Original articleFacile synthesis of benzonitrile/nicotinonitrile based s-triazines as new potential antimycobacterial agents
-
Add time:08/20/2019 Source:sciencedirect.com
A common strategy to synthesize 4/6-(4-(4-methylpiperazin-1-yl)-6-(4-(4-oxo-2-phenylthiazolidin-3-yl)phenyl)-1,3,5-triazin-2-yloxy)benzonitriles/nicotinonitriles was developed by applying an efficient palladium-catalyzed C–C Suzuki coupling. Moreover, the synthesized compounds were also tested for their in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv using BACTEC MGIT and Lowenstein–Jensen MIC methods. Several compounds displayed profound antimycobacterial activity in combination with low toxicity towards mammalian cells. The best results were observed amongst the nicotinonitrile substituted s-triazine analogs and it could be a potential starting point to develop new lead compounds in the fight against M. tuberculosis H37Rv. The newly synthesized compounds were characterized by IR, 1H NMR, 13C NMR, MS and elemental analysis.
We also recommend Trading Suppliers and Manufacturers of 2-Fluoro-4-(4-Methoxyphenyl)benzonitrile (cas 123864-93-7). Pls Click Website Link as below: cas 123864-93-7 suppliers
Prev:Reinvestigating the synthesis of N-arylbenzamidines from benzonitriles and anilines in the presence of AlCl3
Next:Research paperSynthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research paperDesign, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents08/22/2019
- Research paperSynthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis08/21/2019
- Reinvestigating the synthesis of N-arylbenzamidines from benzonitriles and anilines in the presence of AlCl308/19/2019


